3D Matrix Medical Technology
  • Rest of the World
    • France
    • US
  • Products
    • Products
      • PuraStat®
      • Accessories
    • Peptide Technology
      • Advanced Peptide Technology
      • Clinical Studies
  • Professionals
    • Medical Specialities
      • Endoscopic Solutions
      • Cardiac Solutions
      • Ear, Nose and Throat (ENT) Solutions
      • Therapy Innovation
  • Patient
  • About
    • About Us
    • Corporate Information
    • Our Suppliers and Distributors
    • News
Search

News

3-D Matrix: News Page

3dmatrix, haemostatic, japan, purastat, delayed bleeding, ERCP, clinical studies, bleeding management, endoscopic sphincterotomy, endoscopic retrograde cholangiopancreatography

Promising new study evaluating safety and haemostatic efficacy in Endoscopic Retrograde Cholangiopancreatography (ERCP) for Post-Sphincterotomy bleeding.

Endoscopic sphincterotomy (EST) is often performed before bile duct stone removal or metallic stent...
1 minute read
Read More
3dmatrix, events, europe, ent, news, purabond, cardiac, corporate news, plastic, bleeding management, h&n

Corporate and “Meet the experts” events: The winning strategy of 3-D Matrix

3-D Matrix continues to be focused on its events strategy with the aim of continuing to develop its...
1 minute read
Read More
haemostat, 3dmatrix, bleedingmanagement, events, europe, purastat, gastrointestinal, endoscopy, corporate news, GI

3-D Matrix boosts its presence in the European market with a full calendar of GI events

The event season for 3-D Matrix is in full swing. Kicking off the series of events this autumn, it...
1 minute read
Read More
haemostat, 3dmatrix, japan, endoscopy, ERCP, clinical studies, peptide, bleeding management, EST, endoscopic sphincterotomy, endoscopic retrograde cholangiopancreatography

Endoscopic retrograde cholangiopancreatography - PuraStat for effective management of post endoscopic sphincterotomy oozing bleeding: a case series

Endoscopic sphincterotomy (EST) is frequently performed during endoscopic retrograde...
1 minute read
Read More
haemostat, 3dmatrix, ent, purabond, clinical studies, peptide, bleeding management, transoral surgery, robotic surgery

First clinical study evaluating the use of PuraBond for the reduction of post-op haemorrhage and post-op complications in Transoral Robotic Surgery (TORS)

The use of Transoral Robotic surgery (TORS) is increasingly growing in Head and Neck and in Ear,...
1 minute read
Read More
haemostat, 3dmatrix, purastat, gastrointestinal, publication, RADA16, clinical studies, global news, peptide, bleeding management

PuraStat shows its efficacy in achieving endoscopic haemostasis in postoperative anastomotic ulcers

A new interesting case report highlights the efficacy of PuraStat for achieving endoscopic...
1 minute read
Read More
3dmatrix, bleedingmanagement, purastat, news, delayed bleeding, RADA16, GI, clinical studies, Middle East, global news, POPS

A new prospective observational registry (POPS) in the Middle East has launched in Kuwait

3-D Matrix is pleased to announce that a new prospective observational study (POPS) has started in ...
1 minute read
Read More
haemostat, 3dmatrix, europe, purastat, news, purabond, corporate news, RADA16

3-D Matrix Summer Update

3-D Matrix would like to wish you all a wonderful summer and take this opportunity to remind you...
1 minute read
Read More
haemostat, 3dmatrix, events, europe, purastat, news, gastrointestinal, endoscopy, corporate news, RADA16, distributors meeting, GI

3-D Matrix strengthens its relationship with its distribution partners.

During 3-D Matrix's quarterly European sales meeting, held in Barcelona from the 22nd to the 24th...
1 minute read
Read More
3dmatrix, haemostatic, bleedingmanagement, purastat, news, gastrointestinal, delayed bleeding, clinical, RADA16

A new multicentre randomised controlled trial has started in Germany to evaluate PuraStat efficacy in preventing delayed bleeding after endoscopic resections.

The clinical investigation “Prospective, multicentre randomised controlled trial of the...
Read More

Topics

  • 3dmatrix (26)
  • adhesion (1)
  • bleeding management (5)
  • bleedingmanagement (16)
  • cardiac (3)
  • clinical (8)
  • clinical studies (5)
  • corporate news (11)
  • cosmetic (1)
  • delayed bleeding (5)
  • distributors meeting (1)
  • EMR (1)
  • endocrine surgery (1)
  • endonasal surgery (1)
  • endoscopic retrograde cholangiopancreatography (2)
  • endoscopic sphincterotomy (2)
  • endoscopy (6)
  • ent (5)
  • ERCP (3)
  • ESD (1)
  • EST (1)
  • europe (15)
  • events (10)
  • FDA (1)
  • FESS (1)
  • gastrointestinal (11)
  • GI (3)
  • global (10)
  • global news (2)
  • h&n (1)
  • haemostat (13)
  • haemostatic (16)
  • intracranial (1)
  • japan (6)
  • liver (1)
  • manufacturing (2)
  • meethexpert (1)
  • Middle East (1)
  • news (20)
  • NUMAX (1)
  • oral mucosa (1)
  • parathyroidectomy (1)
  • peptide (3)
  • plastic (2)
  • plastic surgery (2)
  • POPS (1)
  • pradeep bhandari (1)
  • publication (7)
  • purabond (8)
  • purasinus (1)
  • purastat (23)
  • RADA16 (8)
  • radiation proctitis (1)
  • RCT (1)
  • robotic surgery (1)
  • study (4)
  • thyroidectomy (1)
  • transoral surgery (1)
  • trial (3)
  • US (3)
  • wound healing (2)
see all topics

Top Posts

Prev 1 2 3 4 Next
3D Matrix Medical Technology
  • Product & Technology
    • Products
      • PuraStat
      • PuraBond
      • Accessories
    • Peptide Technology
      • Peptide Technology
      • Clinical Studies
  • Solutions
    • Endoscopic Solutions
    • Cardiac Solutions
    • Ear, Nose and Throat (ENT) Solutions
    • Laboratory Solutions
    • Therapy Innovation
  • About 3-D Matrix
    • Company History
    • Company Overview
    • Leadership
    • Contact Us
    • Our Suppliers and Distributors

© 2023 3-D Matrix Medical Technology. All Rights Reserved.

Cookie Policy | Sitemap | Privacy Policy | Terms of Use